Jim Simons
KPRX icon

Jim Simons’s Kiora Pharmaceuticals KPRX Stock Holding History

Jim Simons’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,200
Closed -$41.8K – 3493
2025
Q4 		$41.8K Buy
21,200
+8,800
+71% +$20.1K ﹤0.01% 3100
2025
Q3 		$34.5K Buy
+12,400
New +$34.1K ﹤0.01% 3388
2024
Q2 		– Sell
-1,851
Closed -$12K – 3759
2024
Q1 		$12K Sell
1,851
-227
-11% -$1.27K ﹤0.01% 3619
2023
Q4 		$10K Buy
+2,078
New +$10.8K ﹤0.01% 3642
2022
Q3 		– Sell
-116
Closed -$20K – 4248
2022
Q2 		$20K Sell
116
-144
-55% -$24.1K ﹤0.01% 4118
2022
Q1 		$58K Buy
+260
New +$68K ﹤0.01% 3887
2021
Q3 		– Sell
-251
Closed -$328K – 3663
2021
Q2 		$328K Sell
251
-156
-38% -$242K ﹤0.01% 3118
2021
Q1 		$730K Buy
+407
New +$887K ﹤0.01% 2750
2020
Q3 		– Sell
-154
Closed -$267K – 3530
2020
Q2 		$267K Buy
154
+1
+0.7% +$1.88K ﹤0.01% 3081
2020
Q1 		$287K Buy
153
+62
+68% +$133K ﹤0.01% 2995
2019
Q4 		$329K Buy
+91
New +$177K ﹤0.01% 3046

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jim Simons's KPRX Position: Q1 2026 in Review

Jim Simons sold out of Kiora Pharmaceuticals (KPRX) in Q1 2026, closing a stake of 21,200 shares — an estimated $41.8K sold.

Jim Simons first reported a position in KPRX in Q4 2019 and held it in 11 quarters. The position peaked at $730K in Q1 2021. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Jim Simons reported no remaining Kiora Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 21,200 Kiora Pharmaceuticals shares in Q1 2026, an estimated $41.8K.
  • Jim Simons first reported a position in Kiora Pharmaceuticals in Q4 2019 and held it in 11 quarters.
  • Jim Simons's Kiora Pharmaceuticals position peaked at $730K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.